I. Nasibullin

Disrupting tumor onset and growth via selective cell tagging (SeCT) therapy

H. Onoe, Yasuyoshi Watanabe, Katsunori Tanaka, 2021, Science Advances.

Biocompatibility and therapeutic potential of glycosylated albumin artificial metalloenzymes

Katsunori Tanaka, Minoru Yoshida, N. Kudo, 2019, Nature Catalysis.

An artificial metalloenzyme biosensor can detect ethylene gas in fruits and Arabidopsis leaves

Katsunori Tanaka, K. Shirasu, Kenward Vong, 2019, Nature Communications.

Molecular genetic characteristics of F-43 UGSKHA Aeromonas hydrophila bacteriophage

A. A. Nafeev, A. V. Mastilenko, I. Nasibullin, 2019, Vestnik of Ulyanovsk state agricultural academy.

Exploring and Adapting the Molecular Selectivity of Artificial Metalloenzymes

Katsunori Tanaka, Kenward Vong, I. Nasibullin, 2020 .

Synthetic prodrug design enables biocatalytic activation in mice to elicit tumor growth suppression

Katsunori Tanaka, Peni Ahmadi, Kenward Vong, 2022, Nature Communications.

Homo- and Heterogeneous Glycoconjugates on the Basis of N-Glycans and Human Serum Albumin: Synthesis and Biological Evaluation

Katsunori Tanaka, A. Kurbangalieva, I. Nasibullin, 2022, Molecules.

Evaluation of acute toxicity of cancer-targeting albumin-based artificial metalloenzymes.

Tsung-Che Chang, Kyohei Muguruma, Katsunori Tanaka, 2022, Bioorganic & medicinal chemistry.